E-2730
- Generic Name
- E-2730
A Study to Assess the Safety and Tolerability of E2730 After Multiple Dose and the Food Effect After Single Dose in Healthy Participants
- First Posted Date
- 2020-12-21
- Last Posted Date
- 2021-08-26
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT04676685
- Locations
- 🇺🇸
Collaborative Neuroscience Research, LLC., Long Beach, California, United States
A Study to Evaluate the Pharmacodynamic Activity of E2730 in Adult Participants With Photosensitive Epilepsy
- First Posted Date
- 2018-07-27
- Last Posted Date
- 2022-05-04
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT03603639
- Locations
- 🇺🇸
Washington University Hospital, Saint Louis, Missouri, United States
🇺🇸Clinical Trials, Inc. and Arkansas Epilepsy Program, Little Rock, Arkansas, United States
🇺🇸Consultants in Epilepsy & Neurology, PLLC, Boise, Idaho, United States
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730 in Healthy Participants
- First Posted Date
- 2018-03-02
- Last Posted Date
- 2019-03-04
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT03451890
- Locations
- 🇺🇸
Collaborative Neuroscience Network, Long Beach, California, United States
Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730
- First Posted Date
- 2017-02-15
- Last Posted Date
- 2018-09-07
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT03054194
- Locations
- 🇺🇸
Eisai Trial Site, San Antonio, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath